关注
Lin Zhou
标题
引用次数
引用次数
年份
Exploiting aneuploidy-imposed stresses and coping mechanisms to battle cancer
L Zhou, LJ Jilderda, F Foijer
Open Biology 10 (9), 200148, 2020
312020
CRISPR/Cas: a faster and more efficient gene editing system
B Liu, H Xu, J Miao, A Zhang, X Kou, W Li, L Zhou, HG Xie, P Sirois, K Li
Journal of nanoscience and nanotechnology 15 (3), 1946-1959, 2015
252015
Senescent macrophages: a new “old” player in lung cancer development
L Zhou, M Ruscetti
Cancer cell 41 (7), 1201-1203, 2023
72023
A mutation-sensitive switch assay to detect five clinically significant epidermal growth factor receptor mutations
B Liu, L Zhou, Q Wang, K Li
Genetic Testing and Molecular Biomarkers 19 (6), 316-323, 2015
72015
Understanding how genetic mutations collaborate with genomic instability in cancer
LJ Jilderda, L Zhou, F Foijer
Cells 10 (2), 342, 2021
62021
A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers
L Zhou, S Zheng, FR Rosas Bringas, B Bakker, JE Simon, PL Bakker, ...
G3 11 (12), jkab335, 2021
32021
Identification of WNK1 as a therapeutic target to suppress IgH/MYC expression in multiple myeloma
T Ye, AK Mishra, S Banday, R Li, K Hu, MM Coleman, Y Shan, ...
Cell Reports 43 (5), 2024
22024
Abstract B035: Leveraging therapy-induced senescence for prostate cancer immunotherapy
L Zhou, KC Murphy, J Snyder, KD DeMarco, B Ma, M Ruscetti
Cancer Research 83 (11_Supplement), B035-B035, 2023
12023
Abstract A028: Dissecting the role of cellular senescence in prostate cancer initiation and immune suppression
L Zhou, J Snyder, KC Murphy, KD DeMarco, S Chana, K Simin, Z Jiang, ...
Cancer Research 83 (11_Supplement), A028-A028, 2023
12023
Single cell DNA sequencing reveals distinct molecular types of basal cell carcinoma with unique transcriptome features
B Bakker, J Terra, L Zhou, E Racz, S Paljic, J Garcia-Martinez, V Oliveira, ...
BioRxiv, 492199, 2018
12018
Cellular senescence offers distinct immunological vulnerabilities in cancer
L Zhou, B Ma, M Ruscetti
Trends in Cancer, 2024
2024
Abstract C023: P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapy
L Zhou, KD DeMarco, KC Murphy, Z Wu, J Li, J Li, C Johnson, Z Jiang, ...
Cancer Research 84 (22_Supplement), C023-C023, 2024
2024
Abstract PR005: Modulating the immunosuppressive pancreas tumor microenvironment through intratumoral delivery of cytokine-encoding mRNAs
CN Parikh, K De Marco, B Ma, K Murphy, L Chibaya, L Zhou, Y Qiao, ...
Molecular Cancer Therapeutics 23 (11_Supplement), PR005-PR005, 2024
2024
Abstract B059: Modulating the immunosuppressive pancreas tumor microenvironment through intratumoral delivery of cytokine-encoding mRNAs
CN Parikh, K De Marco, K Murphy, L Chibaya, L Zhou, Y Qiao, G Kane, ...
Cancer Research 84 (17_Supplement_2), B059-B059, 2024
2024
MYC and p53 alterations cooperate through VEGF signaling to repress cytotoxic T cell and immunotherapy responses in prostate cancer
KC Murphy, KD DeMarco, L Zhou, Y Lopez-Diaz, Y Ho, J Li, S Bai, ...
bioRxiv, 2024
2024
Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer
SR Chowdhury, KC Murphy, CN Parikh, KD DeMarco, L Zhou, M Ruscetti
Methods in cell biology 190, 171-201, 2024
2024
CDC20 determines the sensitivity to spindle assembly checkpoint (SAC) inhibitors
S Zheng, L Raz, L Zhou, Y Cohen-Sharir, R Tian, R Wardenaar, ...
bioRxiv, 2023.12. 21.572559, 2023
2023
Abstract A078: Identifying and targeting the genetic determinants of immune suppression and immunotherapy failure in prostate cancer
KC Murphy, K DeMarco, Y Lopez-Diaz, L Zhou, M Ruscetti
Cancer Research 83 (11_Supplement), A078-A078, 2023
2023
Exploring the consequences of chromosomal instability in cancer
L Zhou
2022
A CRISPR-Cas9 screen to find the drivers of senescence following chromosomal instability
L Zhou, S Zheng, M Broekhuis, R Wardenaar, NK Chunduri, A Tijhuis, ...
Exploring the consequences of chromosomal instability in cancer, 89, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20